In the context of ERS Congress 2023, Dr Mayer-Hamblett from Seattle Children’s Hospital focused her presentation on the changing landscape in trial design for new CF therapies. How to deal with the new paradigm after Kaftrio? #TogetheragainstCF
Cystic Fibrosis news
The Cystic Fibrosis Spanish Foundation organised the 5th Cystic Fibrosis Update Day
The Spanish Cystic Fibrosis Foundation organised the 5th Cystic Fibrosis Update Day last weekend in Barcelona. The Respiralia Group was represented by Carlos Pons, who was interested in the research projects currently being carried out. Tribute to a lifetime dedicated to Cystic Fibrosis The Spanish Cystic Fibrosis Federation paid tribute to Celestino Raya and Pedro […]
The future of CF treatment lies in a new approach
Professor Marcus Mall from the Christiane Herzog CF Center in Berlin spoke at ERS Congress 2023 about the future of CF treatment being a new therapeutic approach. Challenges ahead for new therapies for cystic fibrosis Dr Mall delved into the research being conducted in people with CF, with a special focus on people with CF […]
